ESAIY (Eisai Co) Valuation Rank


ESAIY Eisai Co Ltd ESAIY
62 GF Score
Price $6.07
GF Value $9.14
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Eisai Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Eisai Co Valuation Rank Related Terms

ESAIY
62GF Score
Eisai Co Ltd ESAIY
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eisai Co (ESAIY) Overvalued in 2026?

Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued. The current stock price of $6.07 is trading 33.6% below its estimated GF Value™ of $9.14. GuruFocus considers Eisai Co to be Significantly Undervalued.

Key valuation signals for ESAIY:

  • Valuation Rank:
  • GF Value™: $9.14 vs. price of $6.07 (33.6% below fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the ESAIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eisai Co Business Description

Address 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
62GF Score

Get the complete analysis for ESAIY

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.07
Price
$9.14
GF Value